Kyu Rhee: Technological Advances Help Diabetes Treatment

Video

IBM Watson Health is working on several projects of their own as well as with partners in the field to move the treatment of diabetes forward in an effort to hep as many patients as possible.

IBM Watson Health is working on several projects of their own as well as with partners in the field to move the treatment of diabetes forward in an effort to hep as many patients as possible.

In addition to adding to the knowledge of its Watson technology Kyu Rhee, MD, MPP, said IBM is adding new programs as well as devices that are all aimed to better help treat patients with diabetes and also work with patients to improve their quality of life. Rhee, chief health officer of IBM Watson Health, discussed the collaborations during the American Diabetes Association's annual meeting in New Orleans.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.